TN govt asked to send medical records of ailing boy to AIIMS

Image
Press Trust of India Chennai
Last Updated : Mar 27 2017 | 10:48 PM IST
The Madras High Court today directed the Tamil Nadu government to forward medical records of a child, who allegedly developed a cancerous tumour after being vaccinated in Erode district, to AIIMS, New Delhi.
A division bench comprising Justices S Nagamuthu and Anitha Sumanth directed the Health Secretary to forward the medical records relating to the child Anbarasu, to AIIMS, Delhi, and Tata Memorial hospital, Mumbai.
It directed the Health Secretary to file the report received from experts on the matter on or before April 5.
The bench gave the direction after perusing the report filed by the Health Secretary along with an enclosure of the Director of Public Health and Preventive medicine, on the steps taken by the state government to treat the child.
The report concluded that the occurrence of cancer following immunisation has not been reported anywhere in the world.
It also stated that Anbarasu was evaluated by a medical team of Adyar Cancer Institute which has given a summary assessment.
The bench posted the matter to April 5 for resumed hearing.
The judges in their order today said the case cannot be simply closed after accepting the statement of the Director of Public Health and Preventive Medicine.
"Therefore as suggested by senior counsel K Kabir (appointed as amicus curiae in the matter to get expert opinion) we are inclined to issue the above direction," it said and ordered the experts to answer a set of queries on the possibility of cancer due to immunisation.
The bench had on March 21, treated the news report published in a Tamil daily as suo motu habeas corpus petition and directed the Chairman, District Child Welfare Committee, Erode, and District Collector to visit Anbarasu and persuade his parents to take the child to hospital for treatment here.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 27 2017 | 10:48 PM IST

Next Story